← Back to Lobbying Governance Index

Novonesis (Novozymes) B

ISIN: DK0010272129 | Denmark | Europe
Score 2 - Moderate
Full assessment

Novozymes sets out a foundational structure for aligning its advocacy with its climate objectives by mobilizing a cross-functional team, but it does not provide clarity on formal oversight or systematic review of its lobbying activities. For instance, the company explains that "we have dedicated regional and global departments for public affairs, regulatory affairs and sustainability" which collaborate "to ensure we a) reach Novozymes internal targets to reduce impact on climate change and b) influence regulation and policy makers to introduce political and regulatory frameworks that incentivize uptake of greener technologies." It further acknowledges engagement on both direct and indirect channels, noting "we engage mostly through policy advocacy, complemented by work with industry and trade associations." However, the company does not disclose any specific individual, board committee or formal audit process charged with reviewing or approving climate-related lobbying, and there is no reference to a published policy framework or monitoring procedure that governs how these engagement activities are overseen or measured for alignment with its climate change strategy.

This assessment is part of the Lobbying Governance Index, covering 8,500 companies scored on whether they have processes to oversee their climate lobbying. See all companies in Europe or all companies in Denmark.